Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Keeping Track: Submissions Galore, And Still More 'Breakthroughs'

Executive Summary

The latest drug development news and highlights from our FDA Performance Tracker.


Related Content

Ground Hog Day For Merck: FDA Again Cancels Sugammadex Advisory Committee Review
Eisai’s Lenvima Will Face Off Against Nexavar In Thyroid Cancer
Nicox PursuesTransformation Into Ophthalmic Specialty Company – And Partner


Related Companies